×

The Board of Nabi Biopharmaceuticals Establishes Ratio for Reverse Stock Split

CONTACT: Nabi Investor Relations 301-770-3099 www.nabi.com Morrow & Co., LLC Attn: Joe Mills 203-658-9400

Nabi Biopharmaceuticals